Professor Gary Richardson is the Group Director of Cabrini Research and holds the Neil Beauglehall Endowed Chair in Medical Oncology Research at Monash University. He is Director of Oncology Clinics Victoria and a Professor of Medicine at Monash University. He previously held the position of Director, Department of Medical Oncology & Clinical Haematology at Monash Medical Centre. He is a Fellow of the Royal Australasian College of Physicians. He trained at St Vincent’s Hospital, the Peter MacCallum Cancer Institute and the National Cancer Institute in the United States. He is past-chairman of the Medical Oncology Group of Australia and past-president of the Private Cancer Physicians of Australia. He is a member of the American Society of Clinical Oncology; the American Association of Cancer Research; the American Association for the Advancement of Science; the Gynaecological Oncology Group; and the International Association for the Study of Lung Cancer. He serves as a member of the International Advisory Committee for the Americal Society of Medical Oncology. He initiated and developed clinical research in haematology and oncology at Cabrini Health and is involved in the design, development and conduct of clinical trials. He is Director of Clinical Research in Medical Oncology and Haematology, and personally acts as principal investigator in many clinical studies in breast, lung, and gynaecological malignancy, as well as development of novel compounds for the treatment of cancer. He established the Family Cancer at Cabrini Clinic, the Oncology Service at Cabrini Brighton, and the apheresis service. He is published many research papers, abstracts, and book chapters. He is past-Chairman of Foundation 49, a Men’s Health Organisation sponsored by Cabrini Health, and is part of the Federal Government advisory board that developed the National Male Health Policy and the Victorian Men’s Health and Wellbeing Strategy. He was awarded the Order of the Australian Medal for services to medical oncology in 2017.